Dehydroepiandrosterone sulfate treatment of mice modulates infection with Schistosoma mansoni
- PMID: 9521152
- PMCID: PMC121367
- DOI: 10.1128/CDLI.5.2.251-253.1998
Dehydroepiandrosterone sulfate treatment of mice modulates infection with Schistosoma mansoni
Abstract
Female mice treated with dehydroepiandrosterone sulfate early during infection were partially protected (P < 0.05-0.005) from Schistosoma mansoni infection. Hormone treatment did not modify parasite-specific cellular or humoral responses. Serum dehydroepiandrosterone sulfate levels and testosterone infection were negatively correlated, r = -0.621 and r = -0.653, respectively, with schistosome worm burden. The partial resistance to schistosome infection in dehydroepiandrosterone sulfate-treated female mice may be due to the known antischistosomular activity of testosterone.
Figures
References
-
- Araneo B A, Woods M L, Daynes R A. Reversal of immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis. 1993;167:830–840. - PubMed
-
- Daneberg H D, Ben-Yehuda A, Zakay-Rones Z, Friedman G. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine. 1995;13:1445–1448. - PubMed
-
- Ebeling P, Koivisto V A. Physiological importance of dehydroepiandrosterone. Lancet. 1994;343:1479–1481. - PubMed
-
- Eloi-Sanots S, Olson N J, Correa-Oliveira R, Colley D G. Schistosoma mansoni: mortality, pathophysiology and susceptibility differences in male and female mice. Exp Parasitol. 1992;75:168–175. - PubMed
-
- Loria R M, Inge T H, Cook S S, Szakal A K, Regelson W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA) J Med Virol. 1988;26:301–314. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
